Tagged with S

Generics Christoph Stoller, general manager for Austria and Germany at Teva was recently elected president of Medicines for Europe, the continent-wide association for the generics and biosimilars industries. Stoller plans to focus his efforts on improving access to generics and biosimilars in Europe, as well as tackling the damaging issue of…

China Eric Bouteiller outlines the paradigm shift occurring in China around rare diseases and how the country has the potential to lead the global pharmaceutical industry in this vital area.   Through exchanges with public officials, academics, representatives of patient associations and industry experts, we sensed a paradigm shift The 8th…

Puerto Rico Jim O’Drobinak, CEO of MCS, one the three largest insurance providers in Puerto Rico, talks about the issues facing the island’s healthcare system, namely chronic underfunding, ageing demography and emigration of doctors, and what the company is doing to tackle these problems. He also stresses the importance of acting on…

Brazil Three seasoned pharma executives with a wealth of experience working in Brazil offer their insights on leadership strategies for success in the massive, but complex, Brazilian pharma market.          Only a 100 percent ethical business is the right business to be conducted. Pius Hornstein, Country Chair, Sanofi…

Thailand Every generation of Novo Nordisk’s insulin portfolio is currently on the Thai Market and the affiliate is one of the fastest-growing pharma multinationals in Thailand. Upon this solid foundation, Novo is now looking to bring the company’s latest and most innovative products to Thailand, branch out into obesity treatments, and…

Taiwan Within Taiwan’s evolving medical device sector, many innovative startups are exploring breakthrough ideas which are sparking global interest and attention – iXensor being a chief example. The company’s patented technology turns mobile devices’ imaging sensors into accurate optical readers, which analyze diagnostic tests in seconds and synchronize results seamlessly to…

Thailand Nares Damrongchai has been the CEO of the Thailand Center of Excellence for Life Science (TCELS) since its foundation in 2004. After seven years onboard, he discusses the organization’s progress in attracting more biotech investment to Thailand and the challenges he has faced along the way.   [Our mission is]…

UAE The top 10 pharma companies in the UAE ranked by 2018 sales according to IQVIA data. Swiss giant Novartis leads the way with USD 196 million in sales, followed by GSK on 129 million and AstraZeneca with 126 million.   Made with Visme Infographic Maker

Clinical Trials Hungary has long been one of the leading countries in Central and Eastern Europe for clinical trials. However, a downward trend in the number of research projects being conducted in the country since 2015 has some stakeholders concerned about the future of Hungary as a regional clinical trials hub.   …

Puerto Rico Michelle Valsega, regional airfreight product director pharma & healthcare for Kuehne and Nagel, shares the latest healthcare logistics trends impacting Puerto Rico and how Kuehne + Nagel uses the island as a centre of innovation to launch and test new solutions.   Kuehne + Nagel has the ambition to be…

China Dr. Zhengyu Yuan, president & CEO of MicuRx, shares the story of how MicuRx was founded in 2007 to develop new and innovative antimicrobial drugs; their flagship product, contezolid, which recently concluded Phase III trials in China; and their future plans for an IPO.   We combined US experience and…

Sweden Swedish Labtech is an industry organization for companies involved in laboratory activities. Chairman Peter Simonsbacka discusses the challenges facing the life science industry, the opportunity to bring back the strong clinical trials tradition in the country and the unique Swedish collaborative ecosystem.   Sweden has a very open environment when…